Literature DB >> 6163876

A/USSR and B/Hong Kong vaccine. Field experiences during an A/Brazil and an influenza B epidemic.

H M Foy, I Allan, J M Blumhagen, M K Cooney, C Hall, J P Fox.   

Abstract

Young adults vaccinated in late spring of 1978 with one dose of vaccine containing either 7 microgram or 20 microgram of A/USSR (H1N1) hemagglutinin, followed by a dose of trivalent (A/USSR, A/Texas, B/Hong Kong) vaccine, were observed through an epidemic of A/Brazil influenza in the winter of 1978-1979, and of influenza B in 1979-1980. Influenza infection was diagnosed by virus isolation or serological titer rises between the spring seasons of 1978, 1979, and 1980. During the A/Brazil epidemic, rates of reported influenza-like illness and serologically confirmed H1N1 influenza infections were similar for all vaccine groups and two control groups. Naturally acquired antibody, but not vaccine-induced hemagglutination-inhibiting antibodies (HAI), appeared protective. During the influenza B epidemic, a lower rate of serologically confirmed infections was observed in the 1978 vaccine cohort than in one control group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163876

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Influenza vaccine match with circulating strains and indicators of influenza strain impact - Canada 1980 to 1992.

Authors:  E Ellis; J M Weber; W Cuff; S G Mackenzie
Journal:  Can J Infect Dis       Date:  1998-05

2.  Seroepidemiological studies on the occurrence of common respiratory infections in paediatric student nurses and medical technology students.

Authors:  H J Gerth; C Grüner; R Müller; K Dietz
Journal:  Epidemiol Infect       Date:  1987-02       Impact factor: 2.451

3.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

4.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

5.  Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice.

Authors:  Gary Wong; Xiangguo Qiu; Hideki Ebihara; Heinz Feldmann; Gary P Kobinger
Journal:  J Infect Dis       Date:  2015-05-28       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.